Preventive measures Transfer genes .. Antibiotic resistance genes (kanamycin, neomycin and ampicillin) have no adverse health effects

Recent research indicates that there is no scientific evidence that the ampacillin resistance gene can be transferred from genetically modified plants to bacteria even if appropriate conditions are available. Research also indicates that 70% of the bovine bacteria, 30% of the bacteria found in ruminants, and 50% of the bacteria in the human's stomach contain an ampacillin resistance gene. Research also indicates that humans take daily 1.2 × 610 (about one and a quarter) bacteria resistant to the antibiotic kanamycin, especially from fresh salads. Thus, the hypothetical transition of the gene to resistance to ampicillin and kanamycin to humans will not provoke anything new. It has also been shown that the protein produced by the sequencing gene of the desirable gene (NPT II) has no adverse health effects as it rapidly decomposes to its constituent amino acids.
Although antibiotic resistance genes (kanamycin, nyomycin and ampicillin) have been shown to have no adverse health effects, there are many other antibiotic resistance genes used in genetically engineered plants, such as hygromycin, bleomycin and gentamycin. Since the presence of such genes on the genetic vector is limited only to the early stages of production of genetically modified plants and has no benefit in the final product, a system called "genetic scissors" has been introduced to remove these genes from genetically modified plants or at least to discontinue them. In order to remove the health concerns altogether and not to increase the level of resistance to antibiotics.